PBM Capital — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Verricaverrica.com in 𝕏NASDAQ: VRCADec 2025

Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma.

BiotechHealthtechMedical DevicesWest Chester, US

Noah Rosenberg(Executive Officer)inJohn Kirby(Executive Officer)Matthew Davidson(Executive Officer, Director)

BoardDavid Zawitz(Executive Officer)

Board seatPaul B. ManningJayson Rieger· per SEC Form D

Co-investorsOrbiMed

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.